Scholarlink

<p>CXC chemokine ligand 8 (<i>CXCL8</i>) has emerged as a critical mediator in tumorigenesis. This study aims to elucidate the role of <i>CXCL8</i> in the initiation and progression of papillary thyroid carcinoma (PTC). Comprehensive bioinformatic analyses were conducted to assess <i>CXCL8</i> expression across pan-cancer datasets, clinical characteristics, biological functions, the tumor immune microenvironment, and single-cell RNA-sequencing data. The expression of <i>CXCL8</i> and its association with clinicopathological features were validated using qRT-PCR and immunohistochemical analysis of tissue microarrays. The data revealed a significantly elevated expression of <i>CXCL8</i> in PTC tissues compared to Paired non-cancerous thyroid tissues(PNTs), with <i>CXCL8</i> expression showing a strong positive correlation with lymph node metastasis. These findings suggest that <i>CXCL8</i> may function as a key molecular contributor to lymph node metastasis in PTC. <i>CXCL8</i> is likely to promote tumor cell proliferation, migration, and invasion via the <i>PI3K-Akt</i> signaling pathway. Moreover, <i>CXCL8</i> expression is closely associated with tumor-infiltrating immune cells, particularly exhibiting high expression levels in dendritic cells. In patients with low <i>CXCL8</i> expression, anti-CTLA-4 immunotherapy may offer superior clinical benefit compared to anti-PD-1 treatment. Collectively, these findings indicate that <i>CXCL8</i> represents a promising biomarker involved in the pathobiology of PTC and constitutes a potential therapeutic target, providing novel insights into immunotherapeutic strategies for PTC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Identification of CXCL8 as a potential gene associated with lymph node metastasis in papillary thyroid carcinoma through bioinformatics analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月25日

查看全文
  • Fenglei Liu,
  • Wenqiao Zhang,
  • Xinyu Gao,
  • Qi xiang,
  • Zhenjun Li,
  • Qian Zhou,
  • Xudong Wei,
  • Ruimin Liu

摘要

CXC chemokine ligand 8 (CXCL8) has emerged as a critical mediator in tumorigenesis. This study aims to elucidate the role of CXCL8 in the initiation and progression of papillary thyroid carcinoma (PTC). Comprehensive bioinformatic analyses were conducted to assess CXCL8 expression across pan-cancer datasets, clinical characteristics, biological functions, the tumor immune microenvironment, and single-cell RNA-sequencing data. The expression of CXCL8 and its association with clinicopathological features were validated using qRT-PCR and immunohistochemical analysis of tissue microarrays. The data revealed a significantly elevated expression of CXCL8 in PTC tissues compared to Paired non-cancerous thyroid tissues(PNTs), with CXCL8 expression showing a strong positive correlation with lymph node metastasis. These findings suggest that CXCL8 may function as a key molecular contributor to lymph node metastasis in PTC. CXCL8 is likely to promote tumor cell proliferation, migration, and invasion via the PI3K-Akt signaling pathway. Moreover, CXCL8 expression is closely associated with tumor-infiltrating immune cells, particularly exhibiting high expression levels in dendritic cells. In patients with low CXCL8 expression, anti-CTLA-4 immunotherapy may offer superior clinical benefit compared to anti-PD-1 treatment. Collectively, these findings indicate that CXCL8 represents a promising biomarker involved in the pathobiology of PTC and constitutes a potential therapeutic target, providing novel insights into immunotherapeutic strategies for PTC.